AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ACTINOGEN MEDICAL LTD

0.043

0.000

Volume:1.55M

Turnover:66.82K

Market Cap:148.86M

PE:-8.70

High:0.044

Open:0.043

Low:0.043

Close:0.043

52wk High:0.072

52wk Low:0.019

Shares:3.46B

Float Shares:2.61B

Volume Ratio:0.19

T/O Rate:0.06%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.005

EPS(LYR):-0.005

ROE:-77.47%

ROA:-41.91%

PB:8.12

PE(LYR):-8.70

Loading ...

Overview Company News Filings

Company Profile

Company Name:

ACTINOGEN MEDICAL LTD

Exchange:

ASX

Establishment Date:

1999

Employees:

6

Office Location:

109 Pitt Street,Suite 901, Level 9,Sydney,New South Wales,Australia

Website:

http://www.actinogen.com.au

Zip Code:

2000

Phone:

Fax:

61 2 8964 7588

Introduction:

Actinogen Medical Limited, a biotechnology company, develops treatments for Alzheimer's disease, and the cognitive deficiency associated with other neurological and metabolic diseases in Australia. It is developing Xanamem, a therapy for Alzheimer's disease; and XanADu, which has completed Phase II clinical trials is a double-blind, randomized, placebo-controlled study to assess the safety, tolerability, and efficacy of Xanamem in subjects with mild dementia due to Alzheimer's disease. The company is also developing XanaHES, a Phase I, single blinded, central reader blinded, placebo-controlled, dose escalation study of Xanamem to assess safety and tolerability in healthy elderly subjects. The company was formerly known as Actinogen Limited and changed its name to Actinogen Medical Limited in November 2015. Actinogen Medical Limited is based in Sydney, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ACW.AU/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ACW.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ACW.AU\",,,,,undefined,":{"symbol":"ACW.AU","market":"AU","secType":"STK","nameCN":"ACTINOGEN MEDICAL LTD","latestPrice":0.043,"timestamp":1770786720000,"preClose":0.043,"halted":0,"volume":1553307,"delay":0,"changeRate":0,"nameEN":"ACTINOGEN MEDICAL LTD","floatShares":2607880613,"shares":3461769000,"eps":-0.004944,"marketStatus":"Not Yet Opened","change":0,"latestTime":"02-11 16:12:00 AEDT","open":0.043,"high":0.044,"low":0.043,"amount":66822,"amplitude":0.023256,"askPrice":0.044,"askSize":699480,"bidPrice":0.043,"bidSize":1211651,"shortable":3,"etf":0,"ttmEps":-0.004944,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1770850800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.043,"openAndCloseTimeList":[[1770764400000,1770786000000]],"volumeRatio":0.193145,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ACW.AU\",,,,,undefined,":{"symbol":"ACW.AU","floatShares":2607880613,"roa":"-41.91%","roe":"-77.47%","lyrEps":-0.004944,"volumeRatio":0.193145,"shares":3461769000,"dividePrice":0,"high":0.044,"amplitude":0.023256,"preClose":0.043,"low":0.043,"week52Low":0.019,"pbRate":"8.12","psRate":"27.12","week52High":0.072,"institutionHeld":0,"latestPrice":0.043,"committee":0.267994,"eps":-0.004944,"divideRate":0,"volume":1553307,"delay":0,"ttmEps":-0.004944,"open":0.043,"prevYearClose":0.061,"prevWeekClose":0.043,"prevMonthClose":0.045,"prevQuarterClose":0.061,"fiveDayClose":0.048,"twentyDayClose":0.051,"sixtyDayClose":0.049,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ACW.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2020-10-19","symbol":"ACW.AU","defaultRemindTime":1603062000000,"type":"split","dateTimestamp":1603026000000,"forFactor":98,"toFactor":100,"ratio":0.98}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ACW.AU\",market:\"AU\",,,undefined,":[],"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":36482293,"yearFounded":1999,"employeeNum":6,"address":"109 Pitt Street,Suite 901, Level 9,Sydney,New South Wales,Australia","zipCode":"2000","officePhone":"61 2 8964 7401","officeFax":"61 2 8964 7588"},"stockCompanyDetail":{"websiteUrl":"http://www.actinogen.com.au","stockEarnings":[{"period":"1week","weight":-0.1042},{"period":"1month","weight":-0.2456},{"period":"3month","weight":-0.1224},{"period":"6month","weight":0.6538},{"period":"1year","weight":0.3437},{"period":"ytd","weight":-0.2951}],"compareEarnings":[{"period":"1week","weight":-0.0113},{"period":"1month","weight":-0.0165},{"period":"3month","weight":0.0074},{"period":"6month","weight":0.0429},{"period":"1year","weight":0.1846},{"period":"ytd","weight":-0.0019}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Actinogen Medical Limited, a biotechnology company, develops treatments for Alzheimer's disease, and the cognitive deficiency associated with other neurological and metabolic diseases in Australia. It is developing Xanamem, a therapy for Alzheimer's disease; and XanADu, which has completed Phase II clinical trials is a double-blind, randomized, placebo-controlled study to assess the safety, tolerability, and efficacy of Xanamem in subjects with mild dementia due to Alzheimer's disease. The company is also developing XanaHES, a Phase I, single blinded, central reader blinded, placebo-controlled, dose escalation study of Xanamem to assess safety and tolerability in healthy elderly subjects. The company was formerly known as Actinogen Limited and changed its name to Actinogen Medical Limited in November 2015. Actinogen Medical Limited is based in Sydney, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.684211,"avgChangeRate":0.079338},{"month":2,"riseRate":0.444444,"avgChangeRate":0.021444},{"month":3,"riseRate":0.5,"avgChangeRate":0.007484},{"month":4,"riseRate":0.333333,"avgChangeRate":0.013585},{"month":5,"riseRate":0.388889,"avgChangeRate":-0.00405},{"month":6,"riseRate":0.470588,"avgChangeRate":0.080013},{"month":7,"riseRate":0.333333,"avgChangeRate":0.056923},{"month":8,"riseRate":0.611111,"avgChangeRate":0.032555},{"month":9,"riseRate":0.388889,"avgChangeRate":0.14023},{"month":10,"riseRate":0.421053,"avgChangeRate":0.113053},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.050767},{"month":12,"riseRate":0.368421,"avgChangeRate":0.004473}],"exchange":"ASX","name":"ACTINOGEN MEDICAL LTD","nameEN":"ACTINOGEN MEDICAL LTD"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ACW.AU\",market:\"AU\",,,undefined,":null}}